By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Scoopico
  • Home
  • U.S.
  • Politics
  • Sports
  • True Crime
  • Entertainment
  • Life
  • Money
  • Tech
  • Travel
Reading: Kamada Ltd. (KMDA) Discusses Discontinuation of Section 3 Inhaled AAT Medical Trial and Monetary Outlook Transcript
Share
Font ResizerAa
ScoopicoScoopico
Search

Search

  • Home
  • U.S.
  • Politics
  • Sports
  • True Crime
  • Entertainment
  • Life
  • Money
  • Tech
  • Travel

Latest Stories

Kalshi locks in  billion valuation, gaining slight edge over its fierce rival Polymarket
Kalshi locks in $22 billion valuation, gaining slight edge over its fierce rival Polymarket
ICE Detains Canadian Mom and Autistic Daughter, Family Claims Trauma
ICE Detains Canadian Mom and Autistic Daughter, Family Claims Trauma
Super Micro co-founder indicted on Nvidia smuggling charges quit board
Super Micro co-founder indicted on Nvidia smuggling charges quit board
Opinion | ‘The Doppelganger Is at the Wheel’
Opinion | ‘The Doppelganger Is at the Wheel’
Today’s Quordle Answers and Hints for March 21, 2026
Today’s Quordle Answers and Hints for March 21, 2026
Have an existing account? Sign In
Follow US
  • Contact Us
  • Privacy Policy
  • Terms of Service
2025 Copyright © Scoopico. All rights reserved
Kamada Ltd. (KMDA) Discusses Discontinuation of Section 3 Inhaled AAT Medical Trial and Monetary Outlook Transcript
Money

Kamada Ltd. (KMDA) Discusses Discontinuation of Section 3 Inhaled AAT Medical Trial and Monetary Outlook Transcript

Scoopico
Last updated: December 8, 2025 3:28 pm
Scoopico
Published: December 8, 2025
Share
SHARE


Operator

Greetings, and welcome to Kamada Company Replace Convention Name. [Operator Instructions] As a reminder, this convention is being recorded.

It’s now my pleasure to introduce your host, Brian Ritchie, Managing Director of LifeSci Advisors. Thanks. Please go forward.

Brian Ritchie
Lifesci Advisors, LLC

Thanks. That is Brian Ritchie with LifeSci Advisors, and thanks all for taking part in right now’s name. Becoming a member of me from Kamada are Amir London, Chief Govt Officer; and Chaime Orlev, Chief Monetary Officer.

Earlier right now, Kamada issued a press launch asserting the corporate’s determination to discontinue its Section III inhaled AAT InnovAATe scientific trial, whereas offering an replace on its monetary projections, that are the topic of right now’s company replace name. If in case you have not obtained this information launch, please go to the Traders web page of the corporate’s web site at www.kamada.com.

Earlier than we start, I want to warning that feedback made throughout this convention name by administration will comprise forward-looking statements that contain dangers and uncertainties concerning the operations and future outcomes of Kamada. I encourage you to evaluate the corporate’s filings with the Securities and Change Fee, together with, with out limitation, the corporate’s Kinds 20-F and 6-Ok, which establish particular components which will trigger precise outcomes or occasions to vary materially from these described within the forward-looking statements.

Moreover, the content material of this convention name comprises time-sensitive info that’s correct solely as of the date of this — of the reside broadcast, Monday, December 8, 2025. Kamada undertakes no obligation to revise or replace any statements to replicate occasions or circumstances

BioMarin Pharmaceutical Inc. (BMRN) Q2 2025 Earnings Name Transcript
Wilbur Ross on Donald Trump’s Stress on the Fed and Jerome Powell
ITOCHU Company 2026 Q2 – Outcomes – Earnings Name Presentation (OTCMKTS:ITOCY) 2025-11-08
Chief individuals officer of a $1.5 billion AI startup is coaching managers on the way to work with Gen Z
Fairness Bancshares, Inc. 2025 Q3 – Outcomes – Earnings Name Presentation (NYSE:EQBK) 2025-10-15
Share This Article
Facebook Email Print

POPULAR

Kalshi locks in  billion valuation, gaining slight edge over its fierce rival Polymarket
Money

Kalshi locks in $22 billion valuation, gaining slight edge over its fierce rival Polymarket

ICE Detains Canadian Mom and Autistic Daughter, Family Claims Trauma
top

ICE Detains Canadian Mom and Autistic Daughter, Family Claims Trauma

Super Micro co-founder indicted on Nvidia smuggling charges quit board
News

Super Micro co-founder indicted on Nvidia smuggling charges quit board

Opinion | ‘The Doppelganger Is at the Wheel’
Opinion

Opinion | ‘The Doppelganger Is at the Wheel’

Today’s Quordle Answers and Hints for March 21, 2026
Sports

Today’s Quordle Answers and Hints for March 21, 2026

Mistral's Small 4 consolidates reasoning, vision and coding into one model — at a fraction of the inference cost
Tech

Mistral's Small 4 consolidates reasoning, vision and coding into one model — at a fraction of the inference cost

Scoopico

Stay ahead with Scoopico — your source for breaking news, bold opinions, trending culture, and sharp reporting across politics, tech, entertainment, and more. No fluff. Just the scoop.

  • Home
  • U.S.
  • Politics
  • Sports
  • True Crime
  • Entertainment
  • Life
  • Money
  • Tech
  • Travel
  • Contact Us
  • Privacy Policy
  • Terms of Service

2025 Copyright © Scoopico. All rights reserved

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?